Clinical Trials
4 trialsNCT04571567 2022-04-11
A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis
Icahn School of Medicine at Mount Sinai
Phase 4 Completed
NCT01961609 2019-03-18
SIGNATURE
Novartis
Phase 3 Completed
NCT02911857 2018-08-20
An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes
Novartis
Phase 3 Completed
NCT01350804 2016-05-23
NURTURE 1
Novartis
Phase 3 Completed